NASDAQ
Myriad Genetics, Inc. (MYGN) has a free cash flow growth of -457.63% as of Friday, May 29, 2026. This represents a 47.48% increase compared to its 12-month average of -871.33%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.